| 8152 | A | 087723 | 001 | DIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ANGIOVIST 370 | BAYER HLTHCARE | 66%;10% | | [] | 1982-09-23 | Sep 23, 1982 | No | No | No | DISCN | BAYER HEALTHCARE PHARMACEUTICALS INC | a1ae9b477f33dd3a6f16f7dd354c78330797e08e7dc6d385885526e020645ba6 |
| 8153 | N | 009372 | 001 | PENTOLINIUM TARTRATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ANSOLYSEN | WYETH AYERST | 10MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | WYETH AYERST LABORATORIES | 8b65377727c576d6f3ee680541c39f342518fd9f384d8f40d320255dd1e9a849 |
| 8154 | N | 020696 | 001 | FOMEPIZOLE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ANTIZOL | PAR PHARM INC | 1.5GM/1.5ML (1GM/ML) | | [] | 1997-12-04 | Dec 4, 1997 | No | Yes | No | DISCN | PAR PHARMACEUTICAL INC | 3fd31f586337e30db3ae695b05634ff429dccc46c9a05eea68e470962d12160e |
| 8155 | N | 020624 | 002 | DOLASETRON MESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ANZEMET | VALIDUS PHARMS | 12.5MG/0.625ML (20MG/ML) | | [] | 1997-09-11 | Sep 11, 1997 | No | Yes | No | DISCN | VALIDUS PHARMACEUTICALS LLC | b882b87b5d8193d484c4e5dadf9f39dca5f8316eee1c43d09432494b23ea583a |
| 8156 | N | 020624 | 001 | DOLASETRON MESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ANZEMET | VALIDUS PHARMS | 100MG/5ML (20MG/ML) | | [] | 1997-09-11 | Sep 11, 1997 | No | Yes | No | DISCN | VALIDUS PHARMACEUTICALS LLC | e19dd2569ae75eb45927b4f3568563de77aae181aff7fee28faeaf21f3d9384e |
| 8157 | N | 020624 | 003 | DOLASETRON MESYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ANZEMET | VALIDUS PHARMS | 500MG/25ML (20MG/ML) | | [] | 2001-12-11 | Dec 11, 2001 | No | No | No | DISCN | VALIDUS PHARMACEUTICALS LLC | c8b8222d23bdcec4c48bdc31d4d4680fb95ad957efc7d4afcb19a7ab3b4fc150 |
| 8158 | A | 062289 | 001 | GENTAMICIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | APOGEN | KING PHARMS | EQ 10MG BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | KING PHARMACEUTICALS INC | 3d4770a427e442f9250ef96b343cb80de3f2cea2e75952e7d37689ff5d3f440c |
| 8159 | A | 062289 | 002 | GENTAMICIN SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | APOGEN | KING PHARMS | EQ 40MG BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | KING PHARMACEUTICALS INC | d65426cd9741d21e841067153011c2a6ea948128199e2796decaa3d72310f266 |
| 8160 | N | 008303 | 003 | HYDRALAZINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | APRESOLINE | NOVARTIS | 20MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | 46d544c2251b1601aad5dad5fefc6e8d3b9a81f8c4108b75f7577348f15f0fbf |
| 8161 | N | 012223 | 002 | PHYTONADIONE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | AQUAMEPHYTON | TELIGENT | 1MG/0.5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | TELIGENT PHARMA INC | bfe827119f0933ee1c47f6b1e4896ff3bc3df61be21d78a05180ceaf9b070667 |
| 8162 | N | 012223 | 001 | PHYTONADIONE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | AQUAMEPHYTON | TELIGENT | 10MG/ML ***Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | TELIGENT PHARMA INC | c7c3adb15ba48efde81a3c95039737a63c70545a419992cddcff7b0a5e56c4ca |
| 8163 | N | 006823 | 001 | VITAMIN A PALMITATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | AQUASOL A | CASPER PHARMA LLC | EQ 50,000 UNITS BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | CASPER PHARMA LLC | 0d974c56cd466cf369015e0f0caa3d4c5db3400dd9dd84d8caf6a381d3608e58 |
| 8164 | N | 006002 | 002 | CHLOROQUINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARALEN HYDROCHLORIDE | SANOFI AVENTIS US | EQ 40MG BASE/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SANOFI AVENTIS US LLC | 1f064b580f130620fb542c2f74f34cd81ff5a6077a54f3fa443899754a27d546 |
| 8165 | N | 009509 | 002 | METARAMINOL BITARTRATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARAMINE | MERCK | EQ 10MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1987-12-22 | Dec 22, 1987 | No | Yes | No | DISCN | MERCK AND CO INC | d980e2cfb768bc00d5a8931fc7369f67d2730bdd86192c7d0a286e356b95c88a |
| 8166 | N | 019638 | 001 | PIPECURONIUM BROMIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARDUAN | ORGANON USA INC | 10MG/VIAL | | [] | 1990-06-26 | Jun 26, 1990 | No | No | No | DISCN | ORGANON USA INC | fc4024ace2e419f0ec3727866d6ddfc0b91429a2b0226356e50fba9ac2f9af71 |
| 8167 | N | 020036 | 001 | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | AREDIA | NOVARTIS | 30MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | 1991-10-31 | Oct 31, 1991 | No | Yes | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | fe10aa953067fc5cea257269497c6c914a17de0182375a6559f05d3a2f592c32 |
| 8168 | N | 020036 | 003 | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | AREDIA | NOVARTIS | 60MG/VIAL | | [] | 1993-05-06 | May 6, 1993 | No | No | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | 5bd7bbf41be72efc02bc69649b1b669451d551e418705240969b9cef27e03780 |
| 8169 | N | 020036 | 004 | PAMIDRONATE DISODIUM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | AREDIA | NOVARTIS | 90MG/VIAL | | [] | 1993-05-06 | May 6, 1993 | No | No | No | DISCN | NOVARTIS PHARMACEUTICALS CORP | ca6ecc1e0a01d4a0ef89389e763ba96b409f6c4144360f5607436ff2442d93a0 |
| 8170 | A | 084777 | 002 | MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARESTOCAINE HYDROCHLORIDE | SOLVAY | 3% | | [] | 1982-04-18 | Apr 18, 1982 | No | No | No | DISCN | SOLVAY PHARMACEUTICALS | 72b42e94945ff6cb06fe8960fb191877fe05e953fad2900f4f7c958522c4d818 |
| 8171 | A | 085010 | 001 | LEVONORDEFRIN; MEPIVACAINE HYDROCHLORIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARESTOCAINE HYDROCHLORIDE W/ LEVONORDEFRIN | SOLVAY | 0.05MG/ML;2% | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | SOLVAY PHARMACEUTICALS | 8ee8336feb2111db8503c4f52bf902a085797fd8f9ba38632cf891749913845d |
| 8172 | N | 008983 | 001 | TRIMETHAPHAN CAMSYLATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARFONAD | ROCHE | 50MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | HOFFMANN LA ROCHE INC | cf26fe3634ae0d7724ee612d7ef635b21bf0e41de8da29a835b6abd7f53cb13e |
| 8173 | A | 206698 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | AMNEAL PHARMS CO | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2018-01-26 | Jan 26, 2018 | No | No | No | RX | AMNEAL PHARMACEUTICALS CO GMBH | 394f6de2886fcbd71e6a59998b370985443a250622894834d36877e58bbac1ea |
| 8174 | A | 214235 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | CAPLIN | 50MG/50ML (1MG/ML) | AP | ["AP"] | 2021-01-21 | Jan 21, 2021 | No | No | No | RX | CAPLIN STERILES LTD | 68ac3806ec4d2dfff98c244f025ad86933b6861eb760ced3e7a684d1e7a20f33 |
| 8175 | N | 201811 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | FRESENIUS KABI USA | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2015-03-23 | Mar 23, 2015 | No | No | No | RX | FRESENIUS KABI USA LLC | 5983ddc4cc829019b23c18d6291a932a3736f653e98a0cf913934376721fa674 |
| 8176 | N | 203049 | 002 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | HIKMA PHARM CO LTD | 50MG/50ML (1MG/ML) | AP | ["AP"] | 2016-09-30 | Sep 30, 2016 | No | Yes | Yes | RX | HIKMA PHARM CO LTD | 3438e8a232499bedffe7a0e9cbeb4d9b729480bb8217d7be058bf1031b925c70 |
| 8177 | N | 203049 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | HIKMA PHARM CO LTD | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2012-01-05 | Jan 5, 2012 | No | Yes | Yes | RX | HIKMA PHARM CO LTD | 4fde42e8feea62d96354581979c490fe25f72b4c36c6f030e7a874f5569ab1f3 |
| 8178 | A | 204120 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | HOSPIRA INC | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2016-09-21 | Sep 21, 2016 | No | No | No | RX | HOSPIRA INC | 1751b86be9c0465066d34bf1f8ba596375562d5555b23f16d529459873cbdcd6 |
| 8179 | A | 202626 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | MYLAN INSTITUTIONAL | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2014-06-30 | Jun 30, 2014 | No | No | No | RX | MYLAN INSTITUTIONAL LLC | b62c3e2da65285f7de4fd30d7e808271debe3bfc2cf1e6bf1643a3147eca3e62 |
| 8180 | N | 020883 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | NOVARTIS | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2000-06-30 | Jun 30, 2000 | No | Yes | Yes | RX | NOVARTIS PHARMACEUTICALS CORP | abec66fff5fe4d9d50ca956995cb6801be297c870907bd0fc8ed5e2fc341edb1 |
| 8181 | A | 091665 | 001 | ARGATROBAN | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARGATROBAN | PAR STERILE PRODUCTS | 250MG/2.5ML (100MG/ML) | AP | ["AP"] | 2014-06-30 | Jun 30, 2014 | No | No | No | RX | PAR STERILE PRODUCTS LLC | 3bb05d8df5a6cb7ad8d5dacf3bbfa20cea53020fc9ac70eec51467455c106dc4 |
| 8182 | N | 011685 | 003 | TRIAMCINOLONE DIACETATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARISTOCORT | FOSUN PHARMA | 25MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | No | No | DISCN | FOSUN PHARMA USA INC | f5a0e896d5551d7158e48c9859ddcdc2eb8dba1c32121e8779ab27f8d159f616 |
| 8183 | N | 012802 | 001 | TRIAMCINOLONE DIACETATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARISTOCORT | FOSUN PHARMA | 40MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | No | DISCN | FOSUN PHARMA USA INC | cde033e59548681ea881c92a08c7572c094b7731d527feddc3afd75c3e219e4b |
| 8184 | N | 016466 | 001 | TRIAMCINOLONE HEXACETONIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARISTOSPAN | SANDOZ INC | 5MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | SANDOZ INC | a548f435fb922dd0329b40c8d9f22eff7708d11066912f9b92ae2e7119c6868e |
| 8185 | N | 016466 | 002 | TRIAMCINOLONE HEXACETONIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARISTOSPAN | SANDOZ INC | 20MG/ML | | [] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | SANDOZ INC | 2b87325abc6aafdd0981eee854ab7b5818c34a05dfb572525f1219edd9d76100 |
| 8186 | A | 210739 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | AMNEAL | 1MG/ML | AP | ["AP"] | 2021-01-25 | Jan 25, 2021 | No | No | No | RX | AMNEAL EU LTD | 8ea25631acdba1f045fbbdb8e18a851a8eb7b49a67c869c86c67cbdd35cea5e4 |
| 8187 | A | 210802 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | AMRING PHARMS | 1MG/ML | AP | ["AP"] | 2018-11-13 | Nov 13, 2018 | No | No | No | RX | AMRING PHARMACEUTICALS INC | 161f0c6656f6bcb2e00ba68a8684f84eabb5023fc4d0725d23b6a29817ab8687 |
| 8188 | A | 208231 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | FRESENIUS KABI USA | 1MG/ML | AP | ["AP"] | 2018-08-31 | Aug 31, 2018 | No | No | No | RX | FRESENIUS KABI USA LLC | 7a542b24d04f243c96541ab25749513920dad695d4580abd78e96464e6513818 |
| 8189 | A | 209315 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | INGENUS PHARMS LLC | 1MG/ML | AP | ["AP"] | 2018-11-15 | Nov 15, 2018 | No | No | No | RX | INGENUS PHARMACEUTICALS LLC | 55925c8722d710946106497c9ac2e678b3aaa9ec19ccd3decddaf354f786969b |
| 8190 | A | 209315 | 002 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | INGENUS PHARMS LLC | 2MG/ML | | [] | 2021-01-14 | Jan 14, 2021 | No | No | No | DISCN | INGENUS PHARMACEUTICALS LLC | 9ab4e82da0f169e96e586d837094a70f9214a880541c2d9024a6942dc3318449 |
| 8191 | A | 209780 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | NEXUS PHARMS | 1MG/ML | AP | ["AP"] | 2018-11-15 | Nov 15, 2018 | No | No | No | RX | NEXUS PHARMACEUTICALS INC | 152322f88848d199f13d41e3783e5c8d4157d91a3675041b38f9c75bdd1ec404 |
| 8192 | A | 209873 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | STI PHARMA LLC | 1MG/ML | AP | ["AP"] | 2019-05-06 | May 6, 2019 | No | No | No | RX | STI PHARMA LLC | 02ad4c8dc121442e4dd92e94420d4ac45b3ea9c11472aba47a46bf73e6020466 |
| 8193 | A | 206228 | 001 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | ZYDUS PHARMS | 1MG/ML | AP | ["AP"] | 2018-11-13 | Nov 13, 2018 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 013cddbe6892f932d5c857b91b2ba22060923dfdc381caef77b16a0b786023e8 |
| 8194 | A | 206228 | 002 | ARSENIC TRIOXIDE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARSENIC TRIOXIDE | ZYDUS PHARMS | 2MG/ML | AP | ["AP"] | 2019-08-30 | Aug 30, 2019 | No | No | No | RX | ZYDUS PHARMACEUTICALS USA INC | 88d1a1f556e67289bba894b9f9c28dfbef61cafc6edef96bde13ae0dc06d8967 |
| 8195 | A | 079138 | 001 | ARTICAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | HOSPIRA | 4%;EQ 0.017MG BASE/1.7ML (4%;EQ 0.01MG BASE/ML) | | [] | 2010-06-18 | Jun 18, 2010 | No | No | No | DISCN | HOSPIRA INC | 6517cdd656935ab8fbbf3bb8bf1c374d2873c282548668a4c129a279ef0fdb4e |
| 8196 | A | 071050 | 001 | MORPHINE SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ASTRAMORPH PF | FRESENIUS KABI USA | 0.5MG/ML | | [] | 1986-10-07 | Oct 7, 1986 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 04d4fc2e6a46e1728833181a5e247e08f1a54490fd378201c8eb3694c8668cf6 |
| 8197 | A | 071051 | 001 | MORPHINE SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ASTRAMORPH PF | FRESENIUS KABI USA | 0.5MG/ML | | [] | 1986-10-07 | Oct 7, 1986 | No | No | No | DISCN | FRESENIUS KABI USA LLC | be9c1df265e9d2ca084a0705a1ea5f16fb08a213060fd72415c58eca5678fe02 |
| 8198 | A | 071052 | 001 | MORPHINE SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ASTRAMORPH PF | FRESENIUS KABI USA | 1MG/ML | | [] | 1986-10-07 | Oct 7, 1986 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 08e2e665b0b944c8bc43ab69dc106c23bed20b8bcb048cc6eef806fe8925d7c7 |
| 8199 | A | 071053 | 001 | MORPHINE SULFATE | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ASTRAMORPH PF | FRESENIUS KABI USA | 1MG/ML | | [] | 1986-10-07 | Oct 7, 1986 | No | No | No | DISCN | FRESENIUS KABI USA LLC | 3c55ac0fd7fb5968e87f59b30a4e7225befd77912866db5e519664de5ea4ad3d |
| 8200 | N | 018140 | 001 | LORAZEPAM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ATIVAN | HIKMA | 2MG/ML | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | HIKMA PHARMACEUTICALS INTERNATIONAL LTD | 362e76c35397778898e43c83efc6f900f48947f7d10c2e027a7764a900175269 |
| 8201 | N | 018140 | 002 | LORAZEPAM | INJECTABLE;INJECTION | INJECTABLE | INJECTION | ATIVAN | HIKMA | 4MG/ML | AP | ["AP"] | | Approved Prior to Jan 1, 1982 | Yes | Yes | Yes | RX | HIKMA PHARMACEUTICALS INTERNATIONAL LTD | 9ee1019772d5dd89673278e8e08e927f4d5e1a0ea852ab1783828306b7444572 |